TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
PRTA

Prothena Corporation plc

Healthcare · Biotechnology

8.60$ +1.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow PRTA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-217.5%
+8.5% +201.1% +26.4% +4.9% +112.1% -77.8% -26.4% -33.3% +24.7% -3.8% +0.2%
+86.1% +139.4% +7.4% +0.9% -12.7% -6.7% +12.0% +27.0% +30.6% +12.3% -18.1%
+35.2% +251.6% +8.7% -104.5% +341.5%
+732.7% +64.6% -137.9% -104.7% -399.1%
+162.7% +1,104.3% -78.2% -51.2% -68.6% -64.7% +193.4% -19.3% +505.6% -89.4% -53.7%
+177.0% +1,104.3% -78.8% -50.9% -68.4% -64.2% +193.4% -19.3% +497.6% -89.3% -53.7%
+16.2% +1.7% +20.7% -73.6% -99.5% -5.7% +43,431.6% -60.6%
+0.0% +0.0% +1,533.1% +59.4%
+19.3% +9.6% +7.2% -75.8% -99.4% -5.7% +88,426.5% +26.9% -81.3% -96.6% -108.9%
-34.1% -73.5% +50.5% -67.3% -630.8% -53.2% -169.3%
-218.7%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?